KPT KP Tissue Inc

KP Tissue Inc. (KPT) (TSX: KPT) reports the Q2 2022 financial and operational results of KPT and Kruger Products L.P. (KPLP). Kruger Products is Canada's leading manufacturer of quality tissue products for the Consumer market (Cashmere®, Purex®, SpongeTowels®, Scotties®, White Swan® and BonterraTM) and the Away-From-Home (AFH) market and continues to expand in the U.S. Consumer market with the White Cloud® brand and premium private label products. KPT currently holds a 14.1% interest in KPLP.

KPLP Q2 2022 Business and Financial Highlights

• Revenue was $397.5 million in Q2 2022 compared to $339.3 million in Q2 2021, an increase of $58.2 million or 17.1%.
• Adjusted EBITDA1 was $11.8 million in Q2 2022, compared to $37.3 million in Q2 2021, a decrease of 68.3%.
• Net loss was $35.5 million in Q2 2022 compared to net income of $2.2 million in Q2 2021, a decrease of $37.7 million.
• Declared a quarterly dividend of $0.18 per share to be paid on October 17, 2022.

“We delivered another strong quarter of double-digit revenue growth in Q2 2022, but the depth, breadth and speed of inflation severely impacted our operating results and lowered profitability,” stated KP Tissue’s Chief Executive Officer, Dino Bianco. “We expect a partial recovery in the third quarter as successive pricing increases begin catching up with the inflationary curve, productivity gains are felt at our Memphis operations, and extensive cost management initiatives take effect. By the end of the fourth quarter, we anticipate a full recovery based on peaked pulp prices and reduced freight rates along with additional pricing adjustments. Consequently, we are highly confident about returning to a normalized margin in the near term.”

“While addressing temporary disruptions head-on, we continued investments in our Sherbrooke Expansion project and AI network implementations, supported our Bonterra, UltraLuxe and White Cloud launches with targeted marketing campaigns, as well as maintained our focus on our sustainable development program. We take particular pride in being ranked fifth overall among the Best 50 Corporate Citizens for 2022 in Canada and first among tissue paper companies, according to latest research from Corporate Knights,” Mr. Bianco added.

Outlook for Q3 2022We anticipate continued momentum in Q3 revenue in both Consumer and AFH and expect selling price increases implemented across the business to begin offsetting the unprecedented cost inflation. As a result, Q3 2022 Adjusted EBITDA1 is expected to be up significantly compared to Q2 2022 in the $28-36 million range.

KPLP Q2 2022 Financial ResultsRevenue was $397.5 million in Q2 2022 compared to $339.3 million in Q2 2021, an increase of $58.2 million or 17.1%. The increase in revenue was due to selling price increases in all segments and regions implemented in the last 12 months, slightly higher sales volume in the Consumer segment and significantly higher sales volume in the AFH segment as the business continues to recover from the impact of COVID-19. Revenue was also favourably impacted by foreign exchange fluctuations on U.S. dollar sales.

Cost of sales was $372.5 million in Q2 2022 compared to $295.0 million in Q2 2021, an increase of $77.5 million or 26.3%. Manufacturing costs increased primarily due to higher sales volumes, significantly increased pulp costs and high inflation on other input costs, along with the impact of labour shortages and productivity in Memphis manufacturing and the unfavourable impact of foreign exchange fluctuations on U.S. dollar costs. Freight costs increased significantly compared to Q2 2021 primarily due to increased freight rates resulting from cost inflation and also higher sales volumes. Warehousing costs also increased compared to the year-ago quarter, primarily due to the ramp-up of TAD Sherbrooke. As a percentage of revenue, cost of sales was 93.7% in Q2 2022 compared to 86.9% in Q2 2021.

Selling, general and administrative (SG&A) expenses were $35.1 million in Q2 2022 compared to $29.6 million in Q2 2021, an increase of $5.5 million or 18.7%. The increase was primarily due to higher advertising and promotion expenses, an increase in personnel costs and higher selling expenses related to increased sales volume. As a percentage of revenue, SG&A expenses were 8.8% in Q2 2022 compared to 8.7% in Q2 2021.

Adjusted EBITDA1 was $11.8 million in Q2 2022 compared to $37.3 million in Q2 2021, a decrease of $25.5 million or 68.3%. The decrease was primarily due to significant inflation on pulp, manufacturing costs and freight as described above and higher SG&A expenses, which were only partially offset by higher sales volume and selling prices.

Net loss was $35.5 million in Q2 2022 compared to net income of $2.2 million in Q2 2021, a decrease of $37.7 million. The decrease was primarily due to lower Adjusted EBITDA of $25.5 million as discussed above, higher other expense and interest expense, partially offset by a higher income tax recovery.

1 Adjusted EBITDA is a non-GAAP financial measure. Refer to the Non-GAAP Financial Measures section of this news release for more information on these measures

KPLP Q2 2022 LiquidityTotal liquidity, representing cash and availability under the revolving credit agreements, was $129.4 million as of June 30, 2022. In addition, $67.8 million of cash was held by KPLP for the TAD Sherbrooke and Sherbrooke Expansion Projects. Also, liquidity will be positively impacted going forward as a result of Kruger Inc.’s decision to increase its participation in the dividend reinvestment plan (DRIP) from 50% to 100% effective July 15, 2022.

KPT Q2 2022 Financial ResultsKPT had a net loss of $3.9 million in Q2 2022. Included in the net loss was $5.1 million representing KPT’s share of KPLP’s net loss, and a dilution gain of $0.1 million, depreciation expense of $1.3 million related to adjustments to carrying amounts on acquisition and an income tax recovery of $2.4 million.

Dividends on Common SharesThe Board of Directors of KPT declared a quarterly dividend of $0.18 per share to be paid on October 17, 2022 to shareholders of record at the close of business on October 3, 2022.

Additional InformationFor additional information please refer to Management’s Discussion and Analysis (MD&A) of KPT and KPLP for the second quarter ended June 30, 2022 available on SEDAR at www.sedar.com or our website at www.kptissueinc.com.

Second Quarter Results Conference Call InformationKPT will hold its second quarter conference call on Thursday, August 11, 2022 at 8:30 a.m. Eastern Time.

Via telephone: 1-888-396-8049 or 416-764-8646

Via the internet at: www.kptissueinc.com

Presentation material referenced during the conference call will be available at www.kptissueinc.com.

A rebroadcast of the conference call will be available until midnight, August 18, 2022 by dialing 1-877-674-7070 or 416-764-8692 and entering passcode 464389.

The replay of the webcast will remain available on the website until midnight, August 18, 2022.

About KP Tissue Inc. (KPT)KPT was created to acquire, and its business is limited to holding, a limited partnership interest in KPLP, which is accounted for as an investment on the equity basis. KPT currently holds a 14.1% interest in KPLP. For more information visit www.kptissueinc.com.

About Kruger Products L.P. (KPLP)KPLP is Canada's leading manufacturer of quality tissue products for household, industrial and commercial use. KPLP serves the Canadian consumer market with such well-known brands as Cashmere®, Purex®, SpongeTowels®, Scotties®, White Swan® and Bonterra™. In the U.S., KPLP manufactures the White Cloud® brand, as well as many private label products. The Away-From-Home division manufactures and distributes high-quality, cost-effective product solutions to a wide range of commercial and public entities. KPLP has approximately 2,700 employees and operates nine FSC® COC-certified (FSC® C-104904) production facilities in North America. For more information visit www.krugerproducts.ca.

Non-GAAP Financial MeasuresThis press release uses certain non-GAAP financial measures which KPLP believes provide useful information to management of KPLP and the readers of the financial information in measuring the financial performance and financial condition of KPLP. These measures do not have a standardized meaning prescribed by GAAP and therefore may not be comparable to similarly titled measures presented by other companies. An example of such a measure is Adjusted EBITDA. Adjusted EBITDA is not a measurement of operating performance computed in accordance with GAAP and should not be considered as a substitute for operating income, net income or cash flows from operating activities computed in accordance with GAAP. “Adjusted EBITDA” is calculated by KPLP as net income (loss) before (i) interest expense and other finance costs, (ii) income taxes, (iii) depreciation, (iv) amortization, (v) impairment (gain on sale) of non-financial assets, (vi) loss (gain) on disposal of property, plant and equipment, (vii) foreign exchange loss (gain), (viii) costs related to restructuring activities, (ix) changes in amortized cost of Partnership units liability, (x) change in fair value of derivatives, (xi) consulting costs related to operational transformation initiatives, (xii) corporate development related costs and (xiii) loss (gain) on sale of shares. A reconciliation of Adjusted EBITDA to the relevant reported results can be found in the Segment and Geographic Results table of this news release.

Forward-Looking StatementsCertain statements in this press release about KPT’s and KPLP's current and future plans, expectations and intentions, results, levels of activity, performance, goals or achievements or any other future events or developments constitute forward-looking statements. Forward-looking statements in this press release include, but are not limited to, statements regarding the projected capacity of the TAD Sherbrooke Project and the Sherbrooke Expansion Project, expected revenue growth and KPLP’s future business strategy. The words "may", "will", "would", "should", "could", "expects", "plans", "intends", "trends", "indications", "anticipates", "believes", "estimates", "predicts", "likely" or "potential" or the negative or other variations of these words or other comparable words or phrases, are intended to identify forward-looking statements. The forward-looking statements are based on certain key expectations and assumptions made by KPT or KPLP. Although KPT and KPLP believe that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking statements since no assurance can be given that such expectations and assumptions will prove to be correct.

The outlook provided in respect of Adjusted EBITDA for Q3 2022 is forward-looking information and is subject to the risk and uncertainties referred to below. The purpose of the outlook is to provide the reader with an indication of management’s expectations, at the date of this press release, regarding KPLP’s future financial performance. Readers are cautioned that this information may not be appropriate for other purposes.

Many factors could cause KPLP’s actual results, level of activity, performance or achievements or future events or developments (which could in turn affect the economic benefits derived from KPT’s economic interest in KPLP), to differ materially from those expressed or implied by the forward-looking statements, including, without limitation, the following factors, which are discussed in greater detail in the “Risk Factors – Risks Related to KPLP’s Business” section of the KPT Annual Information Form dated March 10, 2022 available on SEDAR at www.sedar.com: Kruger Inc.’s influence over KPLP; KPLP’s reliance on Kruger Inc.; consequences of an event of insolvency relating to Kruger Inc.; risks associated with the TAD Sherbrooke Project; risks associated with the Sherbrooke Expansion Project; operational risks; significant increases in input costs; reduction in supply of fibre; increased pricing pressure and intense competition; KPLP’s inability to innovate effectively; adverse economic conditions; dependence on key retail trade customers; damage to the reputation of KPLP or KPLP’s brands; KPLP’s sales being less than anticipated; KPLP’s failure to implement its business and operating strategies; KPLP’s obligation to make regular capital expenditures; KPLP’s entering into unsuccessful acquisitions; KPLP’s dependence on key personnel; KPLP’s inability to retain its existing customers or obtain new customers; KPLP’s loss of key suppliers; KPLP’s failure to adequately protect its intellectual property rights; KPLP’s reliance on third party intellectual property licenses; adverse litigation and other claims affecting KPLP; material expenditures due to comprehensive environmental regulation affecting KPLP’s cash flow; KPLP’s pension obligations are significant and can be materially higher than predicted if KPLP Management’s underlying assumptions are incorrect; labour disputes adversely affecting KPLP’s cost structure and KPLP’s ability to run its plants; exchange rate and U.S. competitors; KPLP’s inability to service all of its indebtedness; exposure to potential consumer product liability; covenant compliance; interest rate and refinancing risk; and risks relating to information technology; cyber-security; insurance; internal controls; trade; and risks related to COVID-19.

Readers should not place undue reliance on forward-looking statements made herein. The forward-looking information contained herein is expressly qualified in its entirety by this cautionary statement. The forward-looking information contained herein is made as of the date of press release and KPT undertakes no obligation to publicly update such forward-looking information to reflect new information, subsequent or otherwise, unless required by applicable securities laws.

INFORMATION:

Francois ParoyanGeneral Counsel and Corporate SecretaryKP Tissue Inc.Tel.: 905.812.6936francois.paroyan@krugerproducts.ca

INVESTORS:

Mike BaldesarraDirector of Investor RelationsKP Tissue Inc. Tel.: 905.812.6962IR@KPTissueinc.com

 

Kruger Products L.P.
Unaudited Condensed Consolidated Statement of Financial Position
(thousands of Canadian dollars)
		June 30, 2022		December 31, 2021
		$		$
Assets
Current assets
	Cash and cash equivalents	95,532		148,519
	Restricted cash	4,818		2,506
	Trade and other receivables	105,736		88,802
	Receivables from related parties	127		271
	Advances to partners	-		13,752
	Inventories	286,203		251,071
	Income tax recoverable	1,465		1,171
	Prepaid expenses	19,522		5,455
		513,403		511,547
Non-current assets
	Property, plant and equipment	1,243,197		1,224,698
	Right-of-use assets	89,968		91,626
	Other long-term assets	33,684		37,456
	Pensions	136,637		-
	Goodwill	152,021		152,021
	Intangible assets	31,920		29,222
	Deferred income taxes	91,805		75,742
Total assets		2,292,635		2,122,312
Liabilities
Current liabilities
	Trade and other payables	250,473		258,626
	Payables to related parties	11,901		11,485
	Income tax payable	149		300
	Distributions payable	12,486		12,300
	Current portion of provisions	1,738		3,705
	Current portion of long-term debt	33,813		48,550
	Current portion of lease liabilities	30,131		30,170
		340,691		365,136
Non-current liabilities
	Long-term debt	1,039,534		920,331
	Long-term lease liabilities	78,636		82,354
	Long-term payable to related party	43,631		42,454
	Long-term provisions	5,653		6,929
	Pensions	-		58,481
	Post-retirement benefits	43,868		57,331
	Liabilities to non-unitholders	1,552,013		1,533,016
	Current portion of Partnership units liability	-		14,064
	Long-term portion of Partnership units liability	159,137		159,137
	Total Partnership units liability	159,137		173,201
Total liabilities		1,711,150		1,706,217
Equity
	Partnership units	472,612		461,536
	Retained earnings (deficit)	32,806		(117,123	)
	Accumulated other comprehensive income	76,067		71,682
Total equity		581,485		416,095
Total equity and liabilities		2,292,635		2,122,312

Kruger Products L.P.
Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss)
(thousands of Canadian dollars)
	3-month period ended June 30, 2022			3-month period ended June 30, 2021			6-month period ended June 30, 2022			6-month period ended June 30, 2021
	$			$			$			$
Revenue	397,499			339,361			796,238			649,740
Expenses
Cost of sales	372,489			294,977			736,344			558,308
Selling, general and administrative expenses	35,111			29,584			63,966			57,349
Loss on sale of non-financial assets	5			2			10			3
Restructuring costs, net	352			(15	)		868			41
Operating income (loss)	(10,458	)		14,813			(4,950	)		34,039
Interest expense and other finance costs	17,369			16,263			34,903			29,185
Other (income) expense	12,599			(631	)		8,284			(947	)
Income (loss) before income taxes	(40,426	)		(819	)		(48,137	)		5,801
Income tax recovery	(4,913	)		(3,066	)		(14,061	)		(3,205	)
Net income (loss) for the period	(35,513	)		2,247			(34,076	)		9,006
Other comprehensive income (loss)
Items that will not be reclassified to net income (loss):
Remeasurements of pensions	89,304			(3,406	)		194,925			94,041
Remeasurements of post-retirement benefits	6,190			(1,420	)		14,051			4,349
Items that may be subsequently reclassified to net income (loss):
Cumulative translation adjustment	8,422			(3,927	)		4,385			(7,372	)
Total other comprehensive income (loss) for the period	103,916			(8,753	)		213,361			91,018
Comprehensive income (loss) for the period	68,403			(6,506	)		179,285			100,024

Kruger Products L.P.
Unaudited Condensed Consolidated Statements of Cash Flows
(thousands of Canadian dollars)
	3-monthperiod endedJune 30, 2022			3-monthperiod endedJune 30, 2021			6-monthperiod endedJune 30, 2022			6-monthperiod endedJune 30, 2021
							$			$
Cash flows from (used in) operating activities
Net income (loss) for the period	(35,513	)		2,247			(34,076	)		9,006
Items not affecting cash
Depreciation	20,778			21,279			42,760			38,735
Amortization	1,125			922			2,169			1,632
Loss on sale of property, plant and equipment	18			264			18			264
Change in amortized cost of Partnership units liability	-			3,428			-			6,856
Foreign exchange (gain) loss	12,599			(4,059	)		8,284			(7,803	)
Interest expense and other finance costs	17,369			16,263			34,903			29,185
Pension and post-retirement benefits	3,576			4,141			7,270			8,143
Provisions	733			(11	)		494			641
Income tax recovery	(4,913	)		(3,066	)		(14,061	)		(3,205	)
Loss on sale of non-financial assets	5			2			10			3
Total items not affecting cash	51,290			39,163			81,847			74,451
Net change in non-cash working capital	(20,031	)		(9,370	)		(66,521	)		(131,825	)
Contributions to pension and post-retirement benefit plans	(4,157	)		(3,813	)		(8,340	)		(7,622	)
Provisions paid	(3,733	)		(3,719	)		(3,915	)		(3,904	)
Income tax payments	(1,168	)		(915	)		(1,488	)		(1,006	)
Net cash from (used in) operating activities	(13,312	)		23,593			(32,493	)		(60,900	)
Cash flows from (used in) investing activities
Purchases of property, plant and equipment	(18,431	)		(8,403	)		(18,930	)		(11,248	)
Purchases of property, plant and equipment and software related to the TAD Sherbrooke Project	(5,598	)		(28,461	)		(10,929	)		(78,940	)
Purchases of property, plant and equipment related to the Sherbrooke Expansion Project	(14,704	)		-			(20,748	)		-
Interest paid on credit facilities related to the TAD Sherbrooke Project	-			-			-			(608	)
Interest paid on credit facilities related to the Sherbrooke Expansion Project	(306	)		-			(306	)		-
Purchases of software	(304	)		(36	)		(4,759	)		(774	)
Proceeds on sale of property, plant and equipment	1			6			1			8
Net cash used in investing activities	(39,342	)		(36,894	)		(55,671	)		(91,562	)
Cash flows from (used in) financing activities
Proceeds from long-term debt	75,550			121,835			217,506			226,475
Repayment of long-term debt	(6,907	)		(1,631	)		(125,446	)		(3,273	)
Payment of deferred financing fees	823			(7,946	)		(1,312	)		(8,270	)
Payment of lease liabilities	(7,426	)		(6,078	)		(14,411	)		(12,715	)
Change in Restricted cash	(1,166	)		(351	)		(2,312	)		(351	)
Interest paid on long-term debt	(16,094	)		(9,520	)		(24,987	)		(16,526	)
Distributions and advances paid, net	(7,046	)		(10,326	)		(14,021	)		(30,861	)
Net cash from financing activities	37,734			85,983			35,017			154,479
Effect of exchange rate changes on cash and cash
equivalents held in foreign currency	426			(874	)		160			(1,396	)
Increase (decrease) in cash and cash equivalents during the period	(14,494	)		71,808			(52,987	)		621
Cash and cash equivalents - Beginning of period	110,026			57,552			148,519			128,739
Cash and cash equivalents - End of period	95,532			129,360			95,532			129,360

Kruger Products L.P.
Segment and Geographic Results
(thousands of Canadian dollars)
	3-month period ended June 30, 2022			3-month period ended June 30, 2021			6-month period ended June 30, 2022			6-month period ended June 30, 2021
	$			$			$			$
Segment Information
Segment Revenue
Consumer	326,333			292,361			669,175			563,728
AFH	71,166			47,000			127,063			86,012
Total segment revenue	397,499			339,361			796,238			649,740
Adjusted EBITDA
Consumer	14,298			40,292			49,681			84,471
AFH	(451	)		(426	)		(3,672	)		(5,336	)
Corporate and other costs	(2,027	)		(2,551	)		(5,134	)		(4,355	)
Total Adjusted EBITDA	11,820			37,315			40,875			74,780
Reconciliation to net income (loss):
Depreciation and amortization	21,903			22,201			44,929			40,367
Interest expense and other finance costs	17,369			16,263			34,903			29,185
Change in amortized cost of Partnership units liability	-			3,428			-			6,856
Loss on sale of property, plant and equipment	18			264			18			264
Loss on sale of non-financial assets	5			2			10			3
Restructuring costs, net	352			(15	)		868			41
Foreign exchange (gain) loss	12,599			(4,059	)		8,284			(7,803	)
Corporate development related costs	-			50			-			66
Income (loss) before income taxes	(40,426	)		(819	)		(48,137	)		5,801
Income tax recovery	(4,913	)		(3,066	)		(14,061	)		(3,205	)
Net income (loss)	(35,513	)		2,247			(34,076	)		9,006
Geographic Revenue
Canada	239,286			219,384			482,206			413,987
US	158,213			119,977			314,032			235,753
Total revenue	397,499			339,361			796,238			649,740

KP Tissue Inc.
Unaudited Condensed Statement of Financial Position
(thousands of Canadian dollars)
	June 30, 2022			December 31, 2021
	$			$
Assets
Current assets
Distributions receivable	1,788			1,781
Income tax recoverable	529			208
	2,317			1,989
Non-current assets
Investment in associate	96,933			78,727
Total Assets	99,250			80,716
Liabilities
Current liabilities
Dividend payable	1,788			1,781
Payable to Partnership	77			246
Current portion of advances from Partnership	-			2,014
	1,865			4,041
Non-current liabilities
Deferred income taxes	7,515			806
Total liabilities	9,380			4,847
Equity
Common shares	22,274			21,844
Contributed surplus	144,819			144,819
Deficit	(90,581	)		(103,561	)
Accumulated other comprehensive income	13,358			12,767
Total equity	89,870			75,869
Total liabilities and equity	99,250			80,716

KP Tissue Inc.
Unaudited Condensed Statements of Comprehensive Income (Loss)
(thousands of Canadian dollars, except share and per share amounts)
	3-month period ended June 30, 2022			3-month period ended June 30, 2021			6-month period ended June 30, 2022			6-month period ended June 30, 2021
	$			$			$			$
Equity loss	(6,423	)		(1,002	)		(7,531	)		(1,347	)
Dilution gain	127			82			200			162
Loss before income taxes	(6,296	)		(920	)		(7,331	)		(1,185	)
Income tax expense (recovery)	(2,348	)		313			(4,361	)		(1,160	)
Net loss for the period	(3,948	)		(1,233	)		(2,970	)		(25	)
Other comprehensive income (loss)
net of tax expense (recovery)
Items that will not be reclassified to net loss:
Remeasurements of pensions	7,884			(443	)		18,132			11,552
Remeasurements of post-retirement benefits	729			(127	)		1,399			389
Items that may be subsequently reclassified to net loss:
Cumulative translation adjustment	1,186			(589	)		591			(1,134	)
Total other comprehensive income (loss) for the period	9,799			(1,159	)		20,122			10,807
Comprehensive income (loss) for the period	5,851			(2,392	)		17,152			10,782
Basic loss per share	(0.40	)		(0.13	)		(0.30	)		-
Weighted average number of shares outstanding	9,935,108			9,817,731			9,930,492			9,798,757

KP Tissue Inc.
Unaudited Condensed Statement of Cash Flows
(thousands of Canadian dollars)
	3-monthperiod endedJune 30, 2022			3-monthperiod endedJune 30, 2021			6-monthperiod endedJune 30, 2022			6-monthperiod endedJune 30, 2021
	$			$			$			$
Cash flows from (used in) operating activities
Net loss for the period	(3,948	)		(1,233	)		(2,970	)		(25	)
Items not affecting cash
Equity loss	6,423			1,002			7,531			1,347
Dilution gain	(127	)		(82	)		(200	)		(162	)
Income tax expense (recovery)	(2,348	)		313			(4,361	)		(1,160	)
Total items not affecting cash	3,948			1,233			2,970			25
Net change in non-cash working capital	(169	)		-			(169	)		(3	)
Tax refunds (payments)	169			(571	)		131			(2,632	)
Tax Distribution received, net	-			-			38			1,738
Advances received	-			571			-			897
Net cash from (used in) operating activities	-			-			-			-
Cash flows from investing activites
Partnership unit distributions received	1,741			1,352			3,144			2,755
Net cash from investing activities	1,741			1,352			3,144			2,755
Cash flows used in financing activities
Dividends paid, net	(1,741	)		(1,352	)		(3,144	)		(2,755	)
Net cash used in financing activities	(1,741	)		(1,352	)		(3,144	)		(2,755	)
Increase (decrease) in cash and cash equivalents during the period	-			-			-			-
Cash and cash equivalents - Beginning of period	-			-			-			-
Cash and cash equivalents - End of period	-			-			-			-